AU2001232020A1 - Floating drug delivery composition - Google Patents

Floating drug delivery composition

Info

Publication number
AU2001232020A1
AU2001232020A1 AU2001232020A AU3202001A AU2001232020A1 AU 2001232020 A1 AU2001232020 A1 AU 2001232020A1 AU 2001232020 A AU2001232020 A AU 2001232020A AU 3202001 A AU3202001 A AU 3202001A AU 2001232020 A1 AU2001232020 A1 AU 2001232020A1
Authority
AU
Australia
Prior art keywords
drug delivery
delivery composition
floating drug
floating
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001232020A
Inventor
John Russell Bond
William Columbus Ian Lafferty
Alan Smith
Peter James Watts
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyowa Kirin Services Ltd
Original Assignee
West Pharmaceutical Services Drug Delivery and Clinical Research Center Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0002882A external-priority patent/GB0002882D0/en
Priority claimed from GB0009775A external-priority patent/GB0009775D0/en
Application filed by West Pharmaceutical Services Drug Delivery and Clinical Research Center Ltd filed Critical West Pharmaceutical Services Drug Delivery and Clinical Research Center Ltd
Publication of AU2001232020A1 publication Critical patent/AU2001232020A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
AU2001232020A 2000-02-09 2001-02-08 Floating drug delivery composition Abandoned AU2001232020A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0002882 2000-02-09
GB0002882A GB0002882D0 (en) 2000-02-09 2000-02-09 Drug delivery composition
GB0009775 2000-04-20
GB0009775A GB0009775D0 (en) 2000-04-20 2000-04-20 Drug delivery composition
PCT/GB2001/000493 WO2001058424A1 (en) 2000-02-09 2001-02-08 Floating drug delivery composition

Publications (1)

Publication Number Publication Date
AU2001232020A1 true AU2001232020A1 (en) 2001-08-20

Family

ID=26243601

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001232020A Abandoned AU2001232020A1 (en) 2000-02-09 2001-02-08 Floating drug delivery composition

Country Status (2)

Country Link
AU (1) AU2001232020A1 (en)
WO (1) WO2001058424A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003037296A2 (en) * 2001-10-29 2003-05-08 Labopharm Inc. Methods and dosage forms for improving the bioavailability of therapeutic agents
ATE419840T1 (en) 2002-04-09 2009-01-15 Flamel Tech Sa ORAL AQUEOUS SUSPENSION CONTAINING MICROCAPSULES FOR THE CONTROLLED RELEASE OF ACTIVE INGREDIENTS
GB0427455D0 (en) * 2004-12-15 2005-01-19 Jagotec Ag Dosage forms
EP2068844A4 (en) * 2006-09-04 2013-01-23 Panacea Biotec Ltd Programmable buoyant delivery technology
EP2133071A1 (en) * 2008-06-09 2009-12-16 Université de la Méditerranée Process for making gastroretentive dosage forms
WO2010026993A1 (en) 2008-09-03 2010-03-11 武田薬品工業株式会社 Method for improving absorbability of preparation, and preparation having improved absorbability
FR2945947B1 (en) * 2009-05-29 2011-07-29 Flamel Tech Sa FLOATING PHARMACEUTICAL COMPOSITIONS WITH CONTROLLED RELEASE
JP5787882B2 (en) 2010-04-30 2015-09-30 武田薬品工業株式会社 Enteric tablets
CA2797809A1 (en) 2010-04-30 2011-11-03 Takeda Pharmaceutical Company Limited Enteric tablet
FR2962550B1 (en) * 2010-07-06 2013-06-14 Ethypharm Sa METHOD FOR CONTROLLING CHEMICAL SUBMISSION, USE OF COLORING AGENT FOR COMBATING CHEMICAL SUBMISSION AND PHARMACEUTICAL COMPOSITION FOR THE IMPLEMENTATION OF THE METHOD
FR2962331B1 (en) * 2010-07-06 2020-04-24 Ethypharm PHARMACEUTICAL FORM FOR COMBATING CHEMICAL SUBMISSION, METHOD USING THE SAME
EP2444064A1 (en) * 2010-10-22 2012-04-25 Meliatys Process for making multiparticulate gastroretentive dosage forms
WO2018213588A1 (en) 2017-05-17 2018-11-22 Massachusetts Institute Of Technology Tissue anchoring articles
US11541015B2 (en) 2017-05-17 2023-01-03 Massachusetts Institute Of Technology Self-righting systems, methods, and related components
WO2019222570A1 (en) 2018-05-17 2019-11-21 Massachusetts Institute Of Technology Systems for electrical stimulation
JP2022523121A (en) 2019-02-01 2022-04-21 マサチューセッツ インスティテュート オブ テクノロジー Systems and methods for liquid injection
WO2020230089A1 (en) 2019-05-14 2020-11-19 Clexio Biosciences Ltd. Treatment of nocturnal symptoms and morning akinesia in subjects with parkinson's disease
US11541216B2 (en) 2019-11-21 2023-01-03 Massachusetts Institute Of Technology Methods for manufacturing tissue interfacing components
WO2022195476A1 (en) 2021-03-15 2022-09-22 Clexio Biosciences Ltd. Gastroretentive devices for assessment of intragastric conditions
CN113855643B (en) * 2021-11-10 2022-11-11 葵花药业集团佳木斯鹿灵制药有限公司 Mesalazine sustained release preparation for colon-specific drug release and preparation process thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3365365A (en) * 1965-08-09 1968-01-23 Hoffmann La Roche Repeat action pharmaceutical compositions in the form of discrete beadlets
US4764380A (en) * 1982-03-22 1988-08-16 Alza Corporation Drug delivery system comprising a volume increasing matrix containing a plurality of tiny pills
GB8507779D0 (en) * 1985-03-26 1985-05-01 Fujisawa Pharmaceutical Co Drug carrier
JPS62195323A (en) * 1986-02-24 1987-08-28 Eisai Co Ltd Gastric resident particle
SE9702533D0 (en) * 1997-07-01 1997-07-01 Astra Ab New oral formulation

Also Published As

Publication number Publication date
WO2001058424A1 (en) 2001-08-16

Similar Documents

Publication Publication Date Title
AU781269C (en) Pharmaceutical compositions
AU2001238386A1 (en) Medication delivery devices
AU2001250420A1 (en) Pharmaceutical compositions
AU2001243567A1 (en) Stent having cover with drug delivery capability
AU2001247360A1 (en) Stent having cover with drug delivery capability
IL152659A0 (en) Pharmaceutical composition
AU2001274307A1 (en) Pharmaceutical compositions
HK1075889A1 (en) Pharmaceutical composition
AU2001232020A1 (en) Floating drug delivery composition
AU3192700A (en) Medicinal compositions
HUP0204555A3 (en) Pharmaceutical composition
AU3556400A (en) Pharmaceutical compositions
AU2005300A (en) Medicinal compositions
AU1887401A (en) Medicinal composition
AU2001275286A1 (en) Transdermal delivery
IL151910A0 (en) Compositions for drug delivery
AU2002258221A1 (en) Medicinal composition
AU2002214324A1 (en) Medicinal compositions
AU2001290239A1 (en) Medicinal composition
IL154238A0 (en) Pharmaceutical composition
AU2001273919A1 (en) Pharmaceutical compositions
AU6460400A (en) Pharmaceutical compositions
AU2001232017A1 (en) Pharmaceutical composition for pulmonary delivery
AU2001232244A1 (en) Drug comprising combination
AU6460200A (en) Pharmaceutical compositions